Role and limitation of cell therapy in treating neurological diseases

Yu-Qi Li, Peng-Fei Li, Qian Tao, Issam J. A. Abuqeis, Yan-Bin Xiyang

PDF
Ibrain ›› 2024, Vol. 10 ›› Issue (1) : 93-105. DOI: 10.1002/ibra.12152
REVIEW

Role and limitation of cell therapy in treating neurological diseases

Author information +
History +

Abstract

The central role of the brain in governing systemic functions within human physiology underscores its paramount significance as the focal point of physiological regulation. The brain, a highly sophisticated organ, orchestrates a diverse array of physiological processes encompassing motor control, sensory perception, cognition, emotion, and the regulation of vital functions, such as heartbeat, respiration, and hormonal equilibrium. A notable attribute of neurological diseases manifests as the depletion of neurons and the occurrence of tissue necrosis subsequent to injury. The transplantation of neural stem cells (NSCs) into the brain exhibits the potential for the replacement of lost neurons and the reconstruction of neural circuits. Furthermore, the transplantation of other types of cells in alternative locations can secrete nutritional factors that indirectly contribute to the restoration of nervous system equilibrium and the mitigation of neural inflammation. This review summarized a comprehensive investigation into the role of NSCs, hematopoietic stem cells, mesenchymal stem cells, and support cells like astrocytes and microglia in alleviating neurological deficits after cell infusion. Moreover, a thorough assessment was undertaken to discuss extant constraints in cellular transplantation therapies, concurrently delineating indispensable model-based methodologies, specifically on organoids, which were essential for guiding prospective research initiatives in this specialized field.

Keywords

cell therapy / mechanism / neurological diseases / organoids

Cite this article

Download citation ▾
Yu-Qi Li, Peng-Fei Li, Qian Tao, Issam J. A. Abuqeis, Yan-Bin Xiyang. Role and limitation of cell therapy in treating neurological diseases. Ibrain, 2024, 10(1): 93‒105 https://doi.org/10.1002/ibra.12152

RIGHTS & PERMISSIONS

2024 2024 The Authors. Ibrain published by Affiliated Hospital of Zunyi Medical University and Wiley-VCH GmbH.
PDF

Accesses

Citations

Detail

Sections
Recommended

/